German diagnostics company recently raised a €4M Series A financing round. Amongst the investors is the .Novel diagnostic solutions for newbornsInfanDx is working on innovative diagnostic solutions for newborns. Within the upcoming 12-18 months, the Cologne-based firm wants to validate its HypoxE® biomarker panel and develop lab and point-of-care prototype settings. Furthermore, a cloud-based interpretation software for the biomarker panel shall be built. InfanDx’s solutions are based on metabolic biomarkers. They reflect the dynamic physiological and pathophysiological events around birth. The firm plans early-adopter use at major academic medical centers in Europe and the US from mid-2022 on.Munich-based Bert Bleicher single family office: Alluti GmbH – Smart InvestAmongst the investors of InfanDx’s Series A are the LSI Pre-Seed Fonds GmbH or Jochen Tschunke. A new investor in the round is the “Alluti GmbH – Smart Invest”, which is the Munich single family office of Bert Bleicher. Alluti invests in private equity deals, impact investments, real estate, mezzanine and financial markets. Bert Bleicher’s wealth is based on the tool distribution company Hoffmann Werkezuge GmbH. Bleicher joined the company in 1996 and brought it to more than €1Bn in revenue.
Source: Picture source: Relevant family office articlesRelevant family office lists Rated 4.00 out of 5 €399,99 including VAT Rated 5.00 out of 5 €299,99 including VAT Rated 4.67 out of 5 €499,99 including VAT Rated 5.00 out of 5 €699,99 including VAT
User Comments1. H.
Green: Comment sample 1...2. E.
Mitchell: Comment sample 2...3. Matthew
Collins: Comment sample 3...4. Ethan A.: Comment sample 4...5. Charlotte Y.: Comment sample 5...Editor's NoteThis article was refined for clarity, structure, and user experience.
(Editors: admin)
Disclaimer & Copyright Notice:
This article is edited and compiled by the editorial team at WealthShield Asia based on publicly available information. It is intended for informational purposes only and does not constitute legal, financial, or investment advice.
We respect intellectual property rights. If you believe that any part of this article infringes upon your copyright or other legal rights, please contact us at
admin@wealthshield.asia. We will promptly review and remove the content if necessary.
All rights reserved. Unauthorized reproduction or redistribution is prohibited.
